Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: A4HE91
Term | Name | Level | Count |
---|---|---|---|
GO:0009987 | cellular process | 1 | 6 |
GO:0016043 | cellular component organization | 3 | 6 |
GO:0022607 | cellular component assembly | 4 | 6 |
GO:0043248 | proteasome assembly | 6 | 6 |
GO:0043933 | protein-containing complex organization | 4 | 6 |
GO:0065003 | protein-containing complex assembly | 5 | 6 |
GO:0071840 | cellular component organization or biogenesis | 2 | 6 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 117 | 121 | PF00656 | 0.501 |
CLV_NRD_NRD_1 | 201 | 203 | PF00675 | 0.529 |
CLV_PCSK_FUR_1 | 199 | 203 | PF00082 | 0.529 |
CLV_PCSK_KEX2_1 | 201 | 203 | PF00082 | 0.529 |
CLV_PCSK_SKI1_1 | 124 | 128 | PF00082 | 0.606 |
CLV_PCSK_SKI1_1 | 207 | 211 | PF00082 | 0.529 |
CLV_PCSK_SKI1_1 | 228 | 232 | PF00082 | 0.574 |
DEG_APCC_DBOX_1 | 206 | 214 | PF00400 | 0.529 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.583 |
DEG_SPOP_SBC_1 | 71 | 75 | PF00917 | 0.567 |
DOC_CYCLIN_RxL_1 | 225 | 233 | PF00134 | 0.599 |
DOC_MAPK_FxFP_2 | 97 | 100 | PF00069 | 0.608 |
DOC_MAPK_MEF2A_6 | 124 | 131 | PF00069 | 0.583 |
DOC_MAPK_MEF2A_6 | 207 | 215 | PF00069 | 0.529 |
DOC_MAPK_NFAT4_5 | 124 | 132 | PF00069 | 0.586 |
DOC_PP1_RVXF_1 | 91 | 98 | PF00149 | 0.629 |
DOC_PP4_FxxP_1 | 97 | 100 | PF00568 | 0.645 |
DOC_USP7_MATH_1 | 21 | 25 | PF00917 | 0.546 |
DOC_USP7_MATH_1 | 72 | 76 | PF00917 | 0.637 |
DOC_USP7_MATH_1 | 79 | 83 | PF00917 | 0.525 |
DOC_WW_Pin1_4 | 169 | 174 | PF00397 | 0.529 |
DOC_WW_Pin1_4 | 19 | 24 | PF00397 | 0.551 |
DOC_WW_Pin1_4 | 246 | 251 | PF00397 | 0.759 |
DOC_WW_Pin1_4 | 26 | 31 | PF00397 | 0.571 |
DOC_WW_Pin1_4 | 41 | 46 | PF00397 | 0.712 |
DOC_WW_Pin1_4 | 75 | 80 | PF00397 | 0.802 |
LIG_14-3-3_CanoR_1 | 60 | 66 | PF00244 | 0.739 |
LIG_14-3-3_CanoR_1 | 81 | 85 | PF00244 | 0.644 |
LIG_BIR_III_4 | 118 | 122 | PF00653 | 0.478 |
LIG_BRCT_BRCA1_1 | 173 | 177 | PF00533 | 0.529 |
LIG_eIF4E_1 | 234 | 240 | PF01652 | 0.343 |
LIG_FHA_1 | 170 | 176 | PF00498 | 0.529 |
LIG_FHA_1 | 187 | 193 | PF00498 | 0.249 |
LIG_FHA_1 | 204 | 210 | PF00498 | 0.249 |
LIG_FHA_1 | 81 | 87 | PF00498 | 0.525 |
LIG_FHA_2 | 108 | 114 | PF00498 | 0.547 |
LIG_FHA_2 | 216 | 222 | PF00498 | 0.261 |
LIG_LIR_Apic_2 | 94 | 100 | PF02991 | 0.634 |
LIG_LIR_Gen_1 | 136 | 145 | PF02991 | 0.569 |
LIG_LIR_Gen_1 | 174 | 183 | PF02991 | 0.529 |
LIG_LIR_Nem_3 | 136 | 140 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 174 | 180 | PF02991 | 0.529 |
LIG_SH2_CRK | 156 | 160 | PF00017 | 0.643 |
LIG_SH2_NCK_1 | 156 | 160 | PF00017 | 0.643 |
LIG_SH2_SRC | 48 | 51 | PF00017 | 0.546 |
LIG_SH2_STAP1 | 48 | 52 | PF00017 | 0.544 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.562 |
LIG_SH2_STAT5 | 234 | 237 | PF00017 | 0.304 |
LIG_SH3_3 | 2 | 8 | PF00018 | 0.551 |
LIG_SH3_3 | 62 | 68 | PF00018 | 0.714 |
LIG_SH3_CIN85_PxpxPR_1 | 7 | 12 | PF14604 | 0.550 |
LIG_TYR_ITIM | 135 | 140 | PF00017 | 0.588 |
MOD_CDK_SPxK_1 | 75 | 81 | PF00069 | 0.555 |
MOD_CK1_1 | 104 | 110 | PF00069 | 0.680 |
MOD_CK1_1 | 19 | 25 | PF00069 | 0.550 |
MOD_CK1_1 | 63 | 69 | PF00069 | 0.634 |
MOD_CK1_1 | 75 | 81 | PF00069 | 0.745 |
MOD_CK2_1 | 107 | 113 | PF00069 | 0.546 |
MOD_CK2_1 | 211 | 217 | PF00069 | 0.261 |
MOD_CK2_1 | 79 | 85 | PF00069 | 0.540 |
MOD_GlcNHglycan | 103 | 106 | PF01048 | 0.490 |
MOD_GlcNHglycan | 163 | 166 | PF01048 | 0.467 |
MOD_GlcNHglycan | 223 | 226 | PF01048 | 0.426 |
MOD_GlcNHglycan | 38 | 41 | PF01048 | 0.559 |
MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.562 |
MOD_GSK3_1 | 101 | 108 | PF00069 | 0.743 |
MOD_GSK3_1 | 140 | 147 | PF00069 | 0.493 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.472 |
MOD_GSK3_1 | 21 | 28 | PF00069 | 0.544 |
MOD_GSK3_1 | 211 | 218 | PF00069 | 0.529 |
MOD_GSK3_1 | 71 | 78 | PF00069 | 0.658 |
MOD_N-GLC_1 | 16 | 21 | PF02516 | 0.562 |
MOD_N-GLC_1 | 41 | 46 | PF02516 | 0.552 |
MOD_N-GLC_1 | 61 | 66 | PF02516 | 0.482 |
MOD_NEK2_1 | 127 | 132 | PF00069 | 0.467 |
MOD_NEK2_1 | 175 | 180 | PF00069 | 0.315 |
MOD_NEK2_1 | 191 | 196 | PF00069 | 0.479 |
MOD_NEK2_1 | 211 | 216 | PF00069 | 0.199 |
MOD_NEK2_1 | 54 | 59 | PF00069 | 0.551 |
MOD_NEK2_1 | 61 | 66 | PF00069 | 0.671 |
MOD_PKA_2 | 80 | 86 | PF00069 | 0.533 |
MOD_Plk_1 | 16 | 22 | PF00069 | 0.560 |
MOD_Plk_1 | 175 | 181 | PF00069 | 0.261 |
MOD_Plk_1 | 61 | 67 | PF00069 | 0.546 |
MOD_Plk_1 | 79 | 85 | PF00069 | 0.485 |
MOD_Plk_2-3 | 171 | 177 | PF00069 | 0.529 |
MOD_Plk_2-3 | 80 | 86 | PF00069 | 0.533 |
MOD_Plk_4 | 211 | 217 | PF00069 | 0.529 |
MOD_ProDKin_1 | 169 | 175 | PF00069 | 0.529 |
MOD_ProDKin_1 | 19 | 25 | PF00069 | 0.550 |
MOD_ProDKin_1 | 26 | 32 | PF00069 | 0.573 |
MOD_ProDKin_1 | 41 | 47 | PF00069 | 0.706 |
MOD_ProDKin_1 | 75 | 81 | PF00069 | 0.803 |
MOD_SUMO_for_1 | 1 | 4 | PF00179 | 0.583 |
TRG_DiLeu_LyEn_5 | 205 | 210 | PF01217 | 0.529 |
TRG_ENDOCYTIC_2 | 137 | 140 | PF00928 | 0.562 |
TRG_ER_diArg_1 | 199 | 202 | PF00400 | 0.529 |
TRG_ER_diArg_1 | 90 | 93 | PF00400 | 0.638 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IGP4 | Leishmania donovani | 76% | 100% |
A4I1N7 | Leishmania infantum | 76% | 100% |
E9AXS1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 76% | 100% |
Q4Q9Q0 | Leishmania major | 75% | 100% |